Novartis urged not to appeal against Indian patent ruling |
The humanitarian group Medecins Sans Frontieres (MSF, Doctors Without Borders) on Wednesday urged Swiss pharmaceutical group Novartis not to challenge an Indian patent law on vital medicines.
"We are asking Novartis not to try to take its case against Indian patent law to the World Trade Organisation or any other body," MSF president Dr. Christophe Fournier said.
Novartis on Monday lost a key patent challenge regarding its cancer medicine Glivec at a court in India's southern city of Chennai.
The group filed the case last year against an Indian law that bans patents for modifications to existing medicines for drugs developed after 1995.